Groowe Groowe / Newsroom / BMY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BMY News

Bristol-Myers Squibb Co.

Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30

prnewswire.com
AMGN SNY BMY LLY

Syngene International verlängert langfristige Forschungszusammenarbeit mit Bristol Myers Squibb bis 2035 USA - Deutsch USA - English India - English USA - español USA - Français Japan - Japanese APAC - Traditional Chinese

prnewswire.com
BMY

Radiation Dose Management Market Set for Strategic Growth, New Report Offers Critical Insights and Competitive Advantage | Astute Analytica

globenewswire.com
AZN BMY GEHC IBM

Syngene International prolonge jusqu'en 2035 sa collaboration à long terme avec Bristol Myers Squibb (BMS) dans le domaine de la recherche USA - Français USA - English India - English USA - español

prnewswire.com
BMY

5G Chipset Competitive Intelligence and Market Forecasts to 2033 by Type, Processing Node Type, Frequency Type, Deployment Type, End Use and Region | Astute Analytica

globenewswire.com
QCOM NVDA T TMUS NXP MRVL ERIC NOK BABA INTC AMD MSFT GOOG AMZN MU SMCI DELL HPQ IBM CSCO AVGO NXPI SWKS ADI MCHP ON TER VRTX BMY MRK PFE JNJ GE BBY VOD GM FORD TSM FOX BYDDF

The T1D Fund Strengthens Expertise With Appointment of Biotech Industry Veteran and Cell Therapy Expert Teresa Foy, Ph.D., to Advance Next Generation of Type 1 Diabetes ("T1D") Therapies

prnewswire.com
BMY

Global Kaposi's Sarcoma Market Accelerates with Rising HIV/AIDS Prevalence and Innovative Treatments

globenewswire.com
BMY PFE MRK BAX

Syngene International extiende su colaboración de investigación con Bristol Myers Squibb USA - español USA - English India - English

prnewswire.com
BMY

U.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships

globenewswire.com
PFE BMY BNTX

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

prnewswire.com
BMY